Cardiopulmonary Stress Testing Systems Market: Global Trends and Forecast Analysis 2023


Posted April 17, 2017 by hawerr

Global cardiopulmonary stress testing systems market was valued at USD 3,307.5 million in 2014 and is anticipated to expand at a CAGR of 8.2% from 2015 to 2023 to reach USD 6,673.0 million in 2023

 
Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure. The cardiopulmonary stress testing systems market report studies the current and future prospects of the market globally. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study. This section also provides overall information and data analysis of the global cardiopulmonary stress testing systems market with respect to leading market segments based on type of product, and geography.

Browse the Complete Report Details at: http://www.transparencymarketresearch.com/cardiopulmonary-stress-testing-systems.html

The market overview section of the report comprises qualitative analysis of the overall cardiopulmonary stress testing systems market, considering the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces Analysis and market attractiveness analysis. In addition, various analyses such as event impact analysis, regulatory framework, market attractiveness analysis by geography, and competitive landscape by key players have been provided. Event impact analysis includes the study of major events such as introduction of new technologies, mergers and acquisitions, and changes that significantly impacted the market. Regulatory framework includes the study of different regulatory norms and procedures that regulate the approval and commercialization of cardiopulmonary stress testing systems and techniques. The market attractiveness analysis is provided to explain the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players take strategic decisions in order to strengthen their positions and expand their shares in the global cardiopulmonary stress testing systems market.

Growing Cases of Cardiac Disorders Worldwide Fuel Market Growth

The high incidence of cardiovascular diseases has been the primary factor driving the demand for cardiopulmonary stress testing systems. According to the World Health Organization (WHO), the coronary artery diseases (CADs) account for nearly 64% of the all the deaths due to cardiovascular conditions. Thus this has been identified as the key cause for a poor quality of life for the majority of women and men across the world. Owing to these reasons the demand for cardiopulmonary stress testing systems has considerably risen in the past few years.

The rise in the geriatric population across the world and the growing problem of obesity have also resulted in a sudden uptake of cardiopulmonary stress testing systems. The aged and the obese are both prone to the risk of coronary artery diseases (CADs), which has had a positive impact on the global market in recent years. Technological advancements, rising disposable incomes, growing awareness about possibilities to treat cardiovascular diseases, and penetration of modern monitoring technology have also resulted in a higher diagnoses rate, which has boosted the demand for cardiopulmonary stress testing systems.

Need to Contain Costs Discourages Hospitals from Investing in Modern Equipment

The enactment of laws such as the Affordable Care Act has been urging the healthcare sector for cost containment to provide affordable healthcare to patients. This trend has been hampering the global market to a severe degree. The reduction in healthcare budgets has prompted large hospitals and private firms to invest less in new equipment and systems to be able to offer an affordable healthcare platform in the longer run. Furthermore, exposure to harmful radiation to due to single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) systems has also discouraged the sales of these systems in the recent past.

Obtain the Sample PDF containing the Upcoming Opportunities and Growth Factors for this Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1530

“The improving healthcare infrastructure of developing countries presents a lucrative growth opportunity to the players in the cardiopulmonary stress testing systems market,” states the lead author of this research report. The expanding business of healthcare insurance, changing lifestyles, and improving purchasing power of consumers will present remarkable opportunities to the overall market in the near future.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Transparency Market Research
Country United States
Categories Health , Medical , Technology
Tags cardiopulmonary stress testing systems market
Last Updated April 17, 2017